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A B S T R A C T
We report an extremely rare case and localization of polypoid angiomiofibroblastoma tumour, a case report and review
of the world literature concerning angiomiofibroblastoma tumour. We present the case of a 74-year-old man who under-
went left anterior and posterior ethmoidectomy with extirpation of tumour mass from left nasal cavity, epipharinx and
left sphenoid sinus. The prognosis for this group of tumour is good and patient didn’t receive any kind of therapy except
surgical treatment. To our knowledge, this is a rare report in the world literature of polypoid angiomiofibroblastoma tu-
mour of nasal cavity. This case indicates that angiomiofibroblastoma tumour of nasal cavity and paranasal sinuses is a
rare disease including its localisation which otolaryngologists should be aware of, and one which should be included in
the differential diagnosis of tumours involving sinonasal tract.
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Introduction
The fibro-myofibroblastic tumour and tumour- like
tumour lesions that can arise from the oral cavity include
nodular fasciitis, solitary fibrous tumor, myofibroma/
myofibromatosis, inflammatory myofibroblastic tumor,
and low-grade myofibroblastic sarcoma1–4. Although sub-
tle morphologic and imunohistochemical differences be-
tween these lesions do ocur, some cases show morpholog-
ical overlapping or hybrid features5–8, indicating they are
histogenetically related lesions arising from common
precursor cell5,8–12. Accordingly, some authors doubt that
these tumors represent distinct entities, suggesting that
they could be better viewed as morphologic variations of
the same disease9,12. Even these variations of the previ-
ously described tumors were reported in oral cavity local-
isation and they are extremely rare, we report on an
unusal tumor occuring as a polypoid mass in left hoana
and epipharinx arising from posterior part of left eth-
moids cells and left sphenoid.
Case Report
A 74- year- old man was referred to our hospital in Oc-
tober 2009 complaining of complete left side nasal ob-
struction. His nasal obstruction started 1 year ago and it
was progressively worse especially last few months. His
past medical history was significant for hypertension
over the past 10 years and the family history was nega-
tive for possible congenital lesions.
Nasal endoscopy with anemization revealed deviation
of the nasal septum and polypoid-like tumour also visual-
ised with posterior rinoscopy. Anemization of nose cavity
did not help him at all of reliving his symptoms of nasal
obstruction. The neck examination was clinically nega-
tive.
Computed tomography scans revealed a tumour mass
in the posterior part of left nasal cavity with spreading in
epiphfarinx, obstructing proximal 3/4 of left hoana and
in cranial direction polypoid mass filling of ethmoid cells
and left sphenoid sinus (Figure 1 and 2).
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Under general anaesthesia, left anterior and posterior
ethmoidectomy was performed with extirpation of whole
tumour mass from left nasal cavity, epipharinx and left
sphenoid sinus. Before that, reconstruction of nasal sep-
tum was performed for better visualising and removing
of tumour mass. Endoscopically, on operation tumour
mass was not looking like a polyp, and operation was per-
formed with minimal bleeding.
Three pieces of tumour mass measuring 2x1 cm, 1x1
cm and 1x0.5 cm was sent for patohistological analysis.
Microscopic examination showed circumscribed, oval le-
sion composed of uniform medium-sized oval cells with
pale eosinophilic cytoplasm with oval nuclei and small
nucleoli. Stromal part of the tumour was consisted of
oedematous collagen with lot of small blood vessels. Mi-
totic activity was absent (Figure 3).
Immunostaining was preformed on the tumour show-
ing expression of CD34, desmin and pan muscle actin.
Positivity for á-smooth muscle actin was only observed in
association with the walls of small blood vessels. The
morphology and expression of CD34, sceletal muscle
markers and desmin confirmed the diagnosis of angio-
myofibroblastoma.
Post-operative recovery was very good. After the con-
sultation with oncologist the patient was reviewed month-
ly. Nine months after the operation, control CT was made
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Fig. 1. Transversal computed tomography showing a tumour
mass in left nasal cavity with spreading in epipharinx and partly
in oropharinx obstructing proximal 3/4 of left hoana.
Fig. 2. Transversal computed tomography showing a tumour
mass in left nasal cavity with spreading in left ethmoidal cells
and in left sphenoidal sinus.
Fig. 3. Photomicrograph showing the tumour composed predomi-
nantly of a relatively uniform population consisting of small- to
medium sized, round to oval- to epithelioid-shaped cells, pale eosi-
nophilic cytoplasm and round to oval nuclei with finely dispersed
chromatin and small nuclei, embedded in a prominent myxoid/
oedematous stroma rich with small blood vessels. (H&E; original
magnification indicated by scale bar corresponding to 100 mm).
Fig. 4. Transversal computed tomography showing left nasal ca-
vity, epipharinx and oropharinx free of tumour mass 9 months
after surgery treatment.
Fig. 5. Transversal computed tomography showing left ethmoi-
dal cells and left sphenoidal sinus free of tumour mass 9 months
after surgery treatment.
and there were no signs of either local tumour recur-
rence or distant metastasis (Figure 4 and 5). Clinical ex-
amination and fiberendoscopy was also negative for tu-
mour reccurence.
Discussion
The tumour that we presented and that was pato-
histologically described as angiomyofibroblastoma is ex-
tremely rare tumour with only few cases documented
worldwide. Previously documented these kinds of tu-
mour were reported in oral cavity and we reported it for
the first time in sinonasal area. It is very difficult to
make an accurate diagnosis of this kind of tumour be-
cause of lack of standardized diagnostic criteria. Micro-
scopic examination showed circumscribed, oval lesion
composed of uniform medium-sized oval cells with pale
eosinophilic cytoplasm with oval nuclei and small nucle-
oli. Stromal part of the tumour was consisted of edema-
tous collagen with lot of small blood vessels. Mitotic ac-
tivity was absent. Immunostaining was preformed on the
tumour showing expression of CD34, desmin and pan
muscle actin. Positivity for á-smooth muscle actin was
only observed in association with the walls of small blood
vessels. The morphology and expression of CD34, sceletal
muscle markers and desmin confirmed the diagnosis of
angiomyofibroblastoma tumour. Although a longer fol-
low-up period is necessary, the absence of atypical mito-
ses, nuclear pleomorphism, and necrosis suggests a fa-
vourable prognosis for the present case.
In our case follow up period was nine months with no
evidence of recurrence of tumor. We suggest that treat-
ment of polypoid angiomyofibroblastoma tumor should
include complete resection of the tumour.
This is further supported by the fact that biological
behaviour of angiomyofibroblastoma of the lower female
genital tract or extragenital sites is usually benign, with
only a low recurrence after complete surgical excision.
Although, fibro- myofibroblastic tumours usually have
low mitotic activity, some cases- especially AMF and cel-
lular angiofibroma (CAF) may show brisk mitotic activ-
ity (up to 11 mitoses per 10 high power fields)13–15. Tu-
mour that we report doesn’t show any mitotic activity
and accordingly small chances for local recurrence but
because these stromal tumours are closely related lesions
arising from a similar fibroblastic-like progenitor cell na-
tive to hormonally responsive specialized stroma12, we
should be aware of recurrence and future possible trans-
formation and differentiation of AMF tumour.
Conclusion
We report a unique case of polypoid angiomyofibro-
blastoma tumour in sinonasal area location with charac-
teristic radiological, histological and immunohistoche-
mical features. These kinds of tumours are rare and
difficult to diagnose. Otolaryngologist should be aware of
this tumour, because, even these tumours are usually be-
nign with only a low recurrence rate after complete sur-
gical excision, some of them may show brisk mitotic ac-
tivity and rarely they could have malignant transforma-
tion. That is one of the reasons why we suggest longer
follow up period for this kind of tumour. Also, angio-
myofibroblastoma should be included in the differential
diagnosis of lesions involving the sinonasal tract. Addi-
tional new cases are necessary to better understand the
clinical-pathologic features of this unusual »fibro-myo-
fibroblastic lesion«, for which the descriptive term »poly-
poid angiomyobibroblastoma-like tumour« seems to be
appropriate. To conclude, even this kind of tumour are
showing expansion and attending to grow, they are not
showing any kind of invasion process what is very impor-
tant factor for overall prognosis and treating for AMF tu-
mours.
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POLIPOIDNI ANGIOMIOFIBROBLASTOM – TUMOR NOSNE [UPLJINE: PRIKAZ BOLESNIKA
S A @ E T A K
Cilj nam je bio prikazati izuzetno rijedak slu~aj i lokalizaciju tumora nosne {upljine – angiomiofibroblastom te njego-
vu lokalizaciju. Pregledali smo i analizirali gotovo svu dostupnu svjetsku medicinsku literaturu vezanu uz ovaj izuzetno
rijetki tumor. Prikazali smo 74 – godi{njeg mu{karca kojemu je u~injena lijeva prednja i stra`nja etmoidektomija s
odstranjenjem tumorske mase iz lijeve nosne {upljine, epifarinksa i lijevog sfenoidnog sinusa. Prognoza za ovaj tip
tumora je dobra te bolesnik nije primio nikakvu drugu terapiju osim kirur{ke. U zaklju~ku, ovo je izuzetno rijetki tu-
mor po svojim patohistolo{kim karakteristikama, kao i po lokalizaciji te bi ga svaki otorinolaringolog trebao imati u
vidu kada razmi{lja o diferencijalnoj dijagnozi tumora nosnih {upljina i sinusa da bi bolje planirao optimalno lije~enje.
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